Immutep (IMMP) Debt Ratio (2014 - 2015)

Immutep (IMMP) posted Debt Ratio of 0.05 for Q2 2015, down 100.0% on a QoQ basis from 72068.18 in Q4 2014.

Immutep (IMMP) Debt Ratio (2014 - 2015) Analysis & Trends

Immutep's Debt Ratio history runs 2 years deep, the most recent figure standing at 0.05 for Q2 2015.

Quarterly Debt Ratio changed N/A year-over-year to 0.05 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was 0.05 (changed N/A YoY) and the FY2015 annual result came in at 0.05, changed N/A from the prior year.
Debt Ratio was 0.05 for Q2 2015 at Immutep, down from 72068.18 in the prior quarter.
Across five years, Debt Ratio topped out at 72068.18 in Q4 2014 and bottomed at 0.05 in Q2 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	1.41
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	0.11
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	0.05
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Immutep	569.08 Mn	569.08 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2015	0.05
Dec 31, 2014	72,068.18